Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WASSABI Trial
NCT01455935Phase 2Unknown
- Sponsor
- Jacobs Neurological Institute
- Start
- Nov 2011
- Primary completion
- Dec 2013
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Jacobs Neurological Institute. Status: unknown.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01455935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455935.